CLDN8 anticorps

N° du produit ABIN7238087

L’anticorps Lapin Polyclonal anti-CLDN8 a été validé pour ELISA et IHC. Il convient pour détecter CLDN8 dans des échantillons de Humain.

Aperçu rapide pour CLDN8 anticorps (ABIN7238087)

Antigène: CLDN8 (Claudin 8 (CLDN8))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CLDN8 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC)

Détail du produit anti-CLDN8 anticorps

Attributs du produit: Polyclonal Antibody

Purification: Affinity purification

Immunogène: Synthetic peptide of human CLDN8

Isotype: IgG

Information d'application

Indications d'application: IHC 1:50-1:200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.6 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur CLDN8

Antigène: CLDN8 (Claudin 8 (CLDN8))

Autre désignation: Claudin 8

Sujet: This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. This protein plays important roles in the paracellular cation barrier of the distal renal tubule, and in the paracellular barrier to prevent sodium back-leakage in distal colon. Differential expression of this gene has been observed in colorectal carcinoma and renal cell tumors, and along with claudin-7, is an immunohistochemical marker for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.

NCBI Accession: NP_955360

UniProt: P56748

Pathways: Hepatitis C